Joardar et al. [31] provided evidence that while modulation of PPARγ activity does not improve lifespan, it represents a promising molecular target for alleviating locomotor dysfunction in Drosophila models of ALS specifically associated with TDP-43 and FUS, but not SOD1. The gene discussed is PPARG; the disease is amyotrophic lateral sclerosis.